Exploring TLR adaptor protein MyD88 as a sensitivity determinant to HDAC inhibitors
<p>Carcinogenesis has shown to be a result of aberrant genetic as well as epigenetic processes. Histone Deacetylase (HDAC) inhibitors, a class of therapeutic agents developed against the latter, have been shown to be efficient against certain haematological malignancies. However, the underlyin...
| Yazar: | |
|---|---|
| Diğer Yazarlar: | |
| Materyal Türü: | Tez |
| Baskı/Yayın Bilgisi: |
2017
|